Corporate News 01-Feb-24
Caplin Point Laboratories to declare Quarterly Result
On 9 February 2024
Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on 9 February 2024.
Previous News
Caplin Point Laboratories consolidated net profit rises 20.23% in the December 2023 quarter
( Results - Announcements 09-Feb-24 14:30 )
Caplin Point Laboratories consolidated net profit rises 22.26% in the September 2022 quarter
( Results - Announcements 12-Nov-22 15:42 )
Caplin Point Laboratories allots 5,000 equity shares under ESOP
( Corporate News - 17-Feb-23 17:23 )
Caplin Point Laboratories fixes record date for interim dividend
( Market Beat - Reports 04-Mar-20 12:51 )
Caplin Steriles receives USFDA approval for Norepinephrine Bitartrate Injection
( Corporate News - 20-Sep-23 11:58 )
Caplin Steriles receives USFDA approval for Phenylephrine hydrochloride Ophthalmic solution
( Corporate News - 24-May-24 12:26 )
Caplin Point's subsidiary gets US FDA approval for blood pressure restoration drug
( Hot Pursuit - 20-Sep-23 11:11 )
Caplin Point Laboratories allots 91,704 equity shares under ESOP
( Corporate News - 15-Dec-22 12:51 )
Caplin Point Laboratories to declare Quarterly Result
( Corporate News - 05-May-22 17:37 )
Caplin Point gains after receiving EIR from USFDA
( Hot Pursuit - 25-Jul-19 15:21 )
Caplin Point Laboratories announces appointment of director of Caplin Steriles
( Corporate News - 11-Apr-19 12:18 )
Other Stories
Board of Restaurant Brands Asia appoints directors
29-Jul-24 18:40
Goa Carbon to declare Quarterly Result
29-Jul-24 17:22
Igarashi Motors India to declare Quarterly Result
29-Jul-24 17:22
Chartered Logistics to convene board meeting
29-Jul-24 17:22
Omax Autos to hold AGM
29-Jul-24 17:22
Kronox Lab Sciences schedules board meeting
29-Jul-24 17:20
QGO Finance to hold AGM
29-Jul-24 17:19
Jamshri Realty announces board meeting date
29-Jul-24 17:18
Deccan Polypacks to hold board meeting
29-Jul-24 17:18
Noida Toll Bridge Company to conduct board meeting
29-Jul-24 17:18
Back
Top
